NG
ELV icon

Novem Group’s Elevance Health ELV Stock Holding History

Novem Group’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$205K Buy
+529
New +$196K 0.02% 427
2026
Q1 		– Sell
-611
Closed -$214K – 453
2025
Q4 		$214K Sell
611
-1,307
-68% -$442K 0.02% 393
2025
Q3 		$620K Buy
1,918
+175
+10% +$54.4K 0.07% 237
2025
Q2 		$678K Buy
1,743
+157
+10% +$63.1K 0.09% 219
2025
Q1 		$690K Buy
1,586
+487
+44% +$195K 0.1% 189
2024
Q4 		$405K Buy
+1,099
New +$460K 0.06% 252

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Novem Group's ELV Position: Q2 2026 in Review

Novem Group opened a new position in Elevance Health (ELV) in Q2 2026: 529 shares worth $205K. The stake represents 0.02% of the portfolio and ranks #427 among its holdings. This is a return to the name: Novem Group previously reported a position in ELV as recently as Q4 2025.

Novem Group first reported a position in ELV in Q4 2024 and has held it in 6 quarters since. The position peaked at $690K in Q1 2025. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Novem Group held 529 shares of Elevance Health worth $205K as of Q2 2026.
  • Elevance Health was a new Novem Group position in Q2 2026.
  • Elevance Health made up 0.02% of Novem Group's portfolio in Q2 2026, its #427 holding.
  • Novem Group first reported a position in Elevance Health in Q4 2024 and has held it in 6 quarters since.
  • Novem Group's Elevance Health position peaked at $690K in Q1 2025.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Novem Group's 13F filing for Q2 2026, filed 21 Jul 2026.